Ragini Kudchadkar

Ragini Kudchadkar

UNVERIFIED PROFILE

Are you Ragini Kudchadkar?   Register this Author

Register author
Ragini Kudchadkar

Ragini Kudchadkar

Publications by authors named "Ragini Kudchadkar"

Are you Ragini Kudchadkar?   Register this Author

77Publications

5642Reads

33Profile Views

Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy.

J Oncol Pharm Pract 2019 Jul 19;25(5):1275-1281. Epub 2018 Aug 19.

2 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Druid Hills, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155218793709DOI Listing
July 2019

Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine.

Cancer Treat Rev 2018 Dec 21;71:8-18. Epub 2018 Sep 21.

Winship Cancer Institute of Emory University, 1365 Clifton Rd NE, Bldg C, Atlanta, GA 30322, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183015
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.09.005DOI Listing
December 2018

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

N Engl J Med 2018 Aug;379(8):722-730

From the University of Texas M.D. Anderson Cancer Center, Houston (H.A.T.); Moffitt Cancer Center and Research Institute, Tampa, FL (P.A.F., N.I.K.); University of California-San Francisco, San Francisco (A. Algazi), the Angeles Clinic and Research Institute, Los Angeles (O.H.), Stanford University Hospital, Palo Alto (R.P.T.), and the Department of Medical Oncology, City of Hope, Duarte (K.M.) - all in California; Dana-Farber Cancer Institute, Boston (F.S.H., D.A.R.); University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill (S.J.M.); University of Colorado Comprehensive Cancer Center, Aurora (K.L.); University of Michigan, Ann Arbor (C.D.L.); Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.A.P.), Roswell Park Cancer Institute, Buffalo (M.S.E., I.P.), and New York University, Lake Success (A.C.P.) - all in New York; Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); Winship Cancer Institute of Emory University, Atlanta (R.R.K.); University of Pittsburgh Medical Center, Pittsburgh (A.T.); Bristol-Myers Squibb, Princeton, NJ (J.J., A. Avila, S.D.); and Cleveland Clinic-Taussig Cancer Institute, Cleveland (A.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805453DOI Listing
August 2018

Practice-Changing Developments in Stage III Melanoma: Surgery, Adjuvant Targeted Therapy, and Immunotherapy.

Am Soc Clin Oncol Educ Book 2018 May;38:759-762

From the Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200241DOI Listing
May 2018

Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients.

J Immunother 2016 Nov/Dec;39(9):355-366

Departments of *Surgery †Hematology and Medical Oncology ‡Surgical Oncology, Winship Cancer Institute §Emory Transplant Center, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117485PMC
December 2017

Systemic Therapy Options for Patients With Unresectable Melanoma.

Am Soc Clin Oncol Educ Book 2017 ;37:661-672

From the Winship Cancer Institute of Emory University, Atlanta, GA; Memorial Sloan Kettering Cancer Center, New York, NY; Institute Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_174934DOI Listing
November 2017

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.

N Engl J Med 2017 11 10;377(19):1824-1835. Epub 2017 Sep 10.

From New York University Perlmutter Cancer Center, New York (J.W.); Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; National and Kapodistrian University of Athens, Athens (H.J.G.); Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France; Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker); Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada; the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia; University of Colorado, Denver (R.G.); Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.); Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); University of Washington, Seattle (S.B.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan; Seoul National University Hospital, Seoul, South Korea (T.M.K.); and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709030DOI Listing
November 2017

Balancing Inflammation: The Link between Th17 and Regulatory T Cells.

Mediators Inflamm 2016 19;2016:6309219. Epub 2016 Jun 19.

Emory Transplant Center of Emory University, 5105 Woodruff Memorial Research Building, 101 Woodruff Circle, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/6309219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930807PMC
May 2017

A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma.

J Immunother Cancer 2016 20;4:85. Epub 2016 Dec 20.

Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612-9416 USA ; New York University Langone Medical Center, New York, NY USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0194-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170897PMC
December 2016

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes.

Am Surg 2016 Nov;82(11):1109-1116

Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
November 2016

Complete response to high-dose IL-2 and enhanced IFNγ+Th17 :  TREG ratio in a melanoma patient.

Melanoma Res 2016 10;26(5):535-9

aEmory University Department of Surgery bEmory University Winship Cancer Institute cEmory Transplant Center, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097185PMC
October 2016

BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.

Melanoma Res 2016 08;26(4):387-94

aDepartment of Radiation Oncology bDepartment of Biostatistics and Bioinformatics Shared Resource cDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia dSoutheast Radiation Oncology Group, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943024PMC
August 2016

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

N Engl J Med 2016 Jun 19;374(26):2542-52. Epub 2016 Apr 19.

From the University of Washington Medical Center (P.T.N., S. Bhatia, N.J.M., E.M.S., M.M.S., J.A.T., M.A.C.), Fred Hutchinson Cancer Research Center (P.T.N., S. Bhatia, S.P.F., L.L., J.A.T., M.A.C.), Cancer Immunotherapy Trials Network (S.P.F., L.L., M.A.C.), and Cancer Research and Biostatistics (A.M., L.R.S.) - all in Seattle; Johns Hopkins University School of Medicine and Kimmel Cancer Center, Baltimore (E.J.L., S. Berry, D.M.P., W.H.S., J.C.S., J.M.T., S.L.T.), and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda. (E.S.) - both in Maryland; Winship Cancer Institute of Emory University, Atlanta (R.R.K.); Merck Research Laboratories, Kenilworth, NJ (L.A., E.K.C., S.M.T., J.H.Y.); University of California, San Francisco, San Francisco (A.D.), and Stanford University, Stanford (H.E.K., K.M., S.A.R.) - both in California; Mt. Sinai Medical Center, New York (P.A.F.); Yale University, New Haven, CT (H.M.K.); and Ohio State University, Columbus (T.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927341PMC
June 2016

Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic Metastases.

Ocul Oncol Pathol 2016 Apr 24;2(3):160-5. Epub 2015 Dec 24.

Department of Pathology, Winship Cancer Institute of Emory University, Atlanta, Ga., USA; Department of Ophthalmology, Winship Cancer Institute of Emory University, Atlanta, Ga., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000442950DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881272PMC
April 2016

Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.

J Clin Oncol 2016 Mar 25;34(8):871-8. Epub 2016 Jan 25.

Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.9345
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.9345DOI Listing
March 2016

Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma.

Melanoma Res 2016 Feb;26(1):35-41

aEmory University School of Medicine Departments of bRadiation Oncology cHematology and Medical Oncology dSurgical Oncology, Winship Cancer Institute eDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health fDepartment of Surgical Pathology and Dermatology, Emory University, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869869PMC
February 2016

BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.

Melanoma Res 2016 Feb;26(1):83-7

Departments of aCutaneous Oncology bAnatomic Pathology, Moffitt Cancer Center Departments of cOncologic Sciences dSurgery, University of South Florida Morsani College of Medicine eDepartment of Pathology, Veterans Administration, Tampa, Florida fDepartment of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia gGeorgetown-Lombardi Comprehensive Cancer Center and Department of Medicine, Medstar-Georgetown University Hospital, Washington, DC, USA hUniversity of Groningen, Department of Surgical Oncology, University Medical Center Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000214DOI Listing
February 2016

Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.

Neuro Oncol 2015 Oct 25;17(10):1312-21. Epub 2015 May 25.

Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia (K.R.P., D.O.-D., M.K.K.); Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia (D.H.L., R.R.K., B.C.C.); School of Medicine, Emory University, Atlanta, Georgia (D.E.O.); Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia (R.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578585PMC
October 2015

XL888 Limits Vemurafenib-Induced Proliferative Skin Events by Suppressing Paradoxical MAPK Activation.

J Invest Dermatol 2015 Oct 3;135(10):2542-2544. Epub 2015 Jun 3.

Department of Tumor Biology, The Moffitt Cancer Center, Tampa, Florida, USA; Department of Cutaneous Oncology, The Moffitt Cancer Center, Tampa, Florida, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2015.205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567904PMC
October 2015

Section IV: non-small cell lung cancer and malignant melanoma.

Curr Probl Cancer 2014 Sep-Oct;38(5):180-98. Epub 2014 Aug 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2014.08.007DOI Listing
June 2015

The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma.

Ann Plast Surg 2015 Jun;74 Suppl 4:S193-7

From the *Division of Plastic Surgery, †University of South Florida Morsani College of Medicine; ‡Cutaneous Oncology Department, Moffitt Cancer Center; §Department of Pathology, University of South Florida Morsani College of Medicine; and ∥Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SAP.0000000000000452DOI Listing
June 2015

The emerging role of radiotherapy for desmoplastic melanoma and implications for future research.

Melanoma Res 2015 Apr;25(2):95-102

aSchool of Medicine bDepartment of Pathology cDepartment of Dermatology, Emory University dDepartment of Radiation Oncology eDepartment of Surgical Oncology fDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000139DOI Listing
April 2015

BRAF and MEK inhibition in melanoma.

Expert Opin Drug Saf 2015 Apr 4;14(4):559-70. Epub 2015 Feb 4.

Moffitt Cancer Center, Complex General Surgical Oncology , 12902 Magnolia Drive, Tampa, FL 33612 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2015.1011618DOI Listing
April 2015

Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.

Clin Cancer Res 2015 Feb 18;21(4):712-20. Epub 2014 Dec 18.

Department of Cutaneous Oncology and Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida. Department of Oncologic Sciences, University of South Florida, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2468DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620684PMC
February 2015

Recent developments in the medical and surgical treatment of melanoma.

CA Cancer J Clin 2014 May-Jun;64(3):171-85. Epub 2014 Mar 26.

Fellow in Hematology/Oncology, Department of Cutaneous Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21224DOI Listing
August 2014

BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies.

Cancer Control 2014 Jul;21(3):221-30

Department of Internal Medicine, Division of Medical Oncology, University of Virginia Health System, Hematology/Oncology, Charlottesville, 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481402100307DOI Listing
July 2014

Integrating molecular biomarkers into current clinical management in melanoma.

Methods Mol Biol 2014 ;1102:27-42

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-62703-727-3_3DOI Listing
June 2014

Melanoma, version 4.2014.

J Natl Compr Canc Netw 2014 May;12(5):621-9

From 1Memorial Sloan-Kettering Cancer Center; 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 3Huntsman Cancer Institute at the University of Utah; 4University of Michigan Comprehensive Cancer Center; 5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 6UC San Diego Moores Cancer Center; 7UCSF Helen Diller Family Comprehensive Cancer Center; 8Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 9St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 10University of Colorado Cancer Center; 11Aim at Melanoma; 12Dana-Farber/Brigham and Women's Cancer Center; 13Vanderbilt-Ingram Cancer Center; 14Roswell Park Cancer Institute; 15Moffitt Cancer Center; 16The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 17Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 18Fox Chase Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Duke Cancer Institute; 21Stanford Cancer Institute; 22Massachusetts General Hospital Cancer Center; 23City of Hope Comprehensive Cancer Center; 24University of Alabama at Birmingham Comprehensive Cancer Center; and 25National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0066DOI Listing
May 2014

Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma.

J Clin Oncol 2013 Dec 21;31(34):4311-8. Epub 2013 Oct 21.

Jeffrey S. Weber, Ragini Reiney Kudchadkar, Bin Yu, Donna Gallenstein, Xiuhua Zhao, Alberto J. Martinez, Wenshi Wang, Geoffrey Gibney, Jodi Kroeger, Cabell Eysmans, Amod A. Sarnaik, and Y. Ann Chen, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and Christine E. Horak and H. David Inzunza, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.4802
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.4802DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837092PMC
December 2013

Recent advances in the treatment of melanoma.

Cancer Control 2013 Oct;20(4):244-5

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481302000401DOI Listing
October 2013

New targeted therapies in melanoma.

Cancer Control 2013 Oct;20(4):282-8

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481302000405DOI Listing
October 2013

Targeted therapy in melanoma.

Clin Dermatol 2013 Mar-Apr;31(2):200-8

Department of Cutaneous Oncology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clindermatol.2012.08.013DOI Listing
August 2013

Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib.

J Am Acad Dermatol 2013 Jul;69(1):e33-4

University of Central Florida College of Medicine, Orlando, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.01.023DOI Listing
July 2013

Pegylated interferon for the adjuvant treatment of melanoma: FDA approved, but what is its role?

Oncologist 2012 21;17(10):1223-4. Epub 2012 Sep 21.

Department of Cutaneous Oncology, 12902 Magnolia Drive, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0368DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481887PMC
June 2013

Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.

Semin Oncol 2012 Apr;39(2):139-44

Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2012.01.011DOI Listing
April 2012

Current and planned multicenter trials for patients with primary or metastatic melanoma.

J Surg Oncol 2011 Sep;104(4):430-7

The Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21867DOI Listing
September 2011

Novel targeted therapies for the treatment of metastatic melanoma.

Ochsner J 2010 ;10(2):117-24

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096194PMC
July 2011

Ipilimumab.

Nat Rev Drug Discov 2011 Jun;10(6):411-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd3463DOI Listing
June 2011

Adjuvant interferon: recommit or move on?

Lancet Oncol 2011 Feb 20;12(2):112-3. Epub 2011 Jan 20.

H Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70005-5DOI Listing
February 2011

Adjuvant therapy for melanoma: a surgical perspective.

Surg Oncol Clin N Am 2011 Jan;20(1):105-14

Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2010.09.001DOI Listing
January 2011

Systemic treatments for merkel cell carcinoma.

Curr Probl Cancer 2010 Jan-Feb;34(1):97-107

Department of Oncologic Sciences, University of South Florida, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2010.01.004DOI Listing
June 2010

The absent-minded professor: an unusual complication of melanoma.

Oncology (Williston Park) 2008 Dec;22(14):1609-14

University of Colorado Health Sciences Cencer, CO 80045, USA.

View Article

Download full-text PDF

Source
December 2008

PI-88: a novel inhibitor of angiogenesis.

Expert Opin Investig Drugs 2008 Nov;17(11):1769-76

University of Colorado Cancer Center, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.17.11.1769DOI Listing
November 2008

A case of Merkel cell carcinoma.

Oncology (Williston Park) 2008 Mar;22(3):322-8

Department of Cutaneous Oncology, University of Colorado at Denver Health Sciences Center, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
March 2008